Details of the Drug Formulations

General Information of Drug (ID: DMXLVDT)

Drug Name
Lasmiditan Drug Info
Synonyms COL-144; LY-573144; Migraine therapy, CoLucid
Indication
Disease Entry ICD 11 Status REF
Migraine 8A80 Approved [1]
Cross-matching ID
PubChem CID
11610526
CAS Number
439239-90-4
TTD ID
D01NQM
ACDINA ID
D01198

Full List of Drug Formulations Containing This Drug

Lasmiditan 100 mg tablet
Company Formulation ID FDA Description
Eli Lilly And F23800 Croscarmellose Sodium; Magnesium Stearate; Microcrystalline Cellulose; Pregelatinized Starch; Sodium Lauryl Sulfate; Black Ferric Oxide; Polyethylene Glycol; Polyvinyl Alcohol; Red Ferric Oxide; Talc; Titanium Dioxide
------------------------------------------------------------------------------------
Lasmiditan 50 mg tablet
Company Formulation ID FDA Description
Eli Lilly And F24078 Croscarmellose Sodium; Magnesium Stearate; Microcrystalline Cellulose; Pregelatinized Starch; Sodium Lauryl Sulfate; Black Ferric Oxide; Polyethylene Glycol; Polyvinyl Alcohol; Talc; Titanium Dioxide
------------------------------------------------------------------------------------
Lasmiditan 200 mg tablet
Company Formulation ID FDA Description
Eli Lilly And F24079 Croscarmellose Sodium; Magnesium Stearate; Microcrystalline Cellulose; Pregelatinized Starch; Sodium Lauryl Sulfate; Black Ferric Oxide; Polyethylene Glycol; Polyvinyl Alcohol; Talc; Titanium Dioxide
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019